1. US scientists release guidance on COVID-19 vaccine distribution Full story
2. NIH questions evidence backing FDA's emergency authorization for convalescent plasma as COVID-19 treatment Full story
3. US decision to abstain from WHO-backed vaccine initiative 'awkward, contradictory and self-defeating,' expert says Full story
4. Data analytics + hospital pharmacy = cash. Attend this pharma-focused virtual discussion to learn how big data can help hospitals survive the economic downturn.
5. Sanofi, Regeneron say rheumatoid arthritis drug Kevzara failed as COVID-19 treatment Full story
6. California legislature OKs bill to create state-run generic drug company Full story
7. Join us at Becker's first ever Pharmacy Virtual Forum - click here to register!
8. Mylan launches low-cost insulin biosimilar Full story
9. Congress to subpoena AbbVie for providing 'particularly poor' drug pricing documents Full story
10. AstraZeneca signing up patients for phase 3 COVID-19 vaccine trial Full story
11. Outcomes management in a new landscape — insights for dental groups. Click here to attend.
12. Daily COVID-19 stats, state-by-state: